Novartis Ag (NVS) Total Debt (2009 - 2026)

Novartis Ag (NVS) has 13 years of Total Debt data on file, last reported at -$19.0 million in Q1 2026.

• Quarterly Total Debt changed N/A year-over-year to -$19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.0 million (changed N/A YoY) and the FY2025 annual result came in at $28.7 billion, up 30.54% from the prior year.
• Total Debt retreated to -$19.0 million in Q1 2026 per NVS's latest filing, from $28.7 billion in the prior quarter.
• The five-year high for Total Debt was $30.8 billion in Q2 2025, with the low at -$19.0 million in Q1 2026.
• Average Total Debt over 5 years is $20.2 billion, with a median of $24.1 billion recorded in 2022.
• Year-over-year, Total Debt tumbled 37.6% in 2022 and jumped 30.54% in 2025.
• Novartis Ag's Total Debt stood at $26.2 billion in 2022, then declined by 27.18% to $19.1 billion in 2023, then increased by 15.47% to $22.0 billion in 2024, then jumped by 30.54% to $28.7 billion in 2025, then tumbled by 100.07% to -$19.0 million in 2026.
• Business Quant data shows NVS's Total Debt at -$19.0 million in Q1 2026, $28.7 billion in Q4 2025, and -$9.0 million in Q3 2025.